OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
5
Results
Show all
Save search
Copy query
Show results for
Unknown
(5)
Publication Date
Release Date
2024
(1)
2023
(1)
2022
(1)
2019
(1)
2016
(1)
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia.
Not available
S-EPMC6368236
|
biostudies-literature
Cite
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with
NPM1
-mutated AML unfit for intensive chemotherapy and review of the literature.
Not available
S-EPMC5134148
|
biostudies-literature
Cite
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial.
Not available
S-EPMC11375254
|
biostudies-literature
Cite
Prediction of morbidity and mortality after early cholecystectomy for acute calculous cholecystitis: results of the S.P.Ri.M.A.C.C. study.
Not available
S-EPMC10024826
|
biostudies-literature
Cite
The ChoCO-W prospective observational global study: Does COVID-19 increase gangrenous cholecystitis?
Not available
S-EPMC9755784
|
biostudies-literature
Cite
Previous
page
1 / 1
You're on page
1
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets